You have 9 free searches left this month | for more free features.

City

New Haven (1)

Condition

Advanced Triple Negative Breast Cancer (1)

Malignant Melanoma (1)

Mesothelioma (1)

Non Small Cell Lung Cancer (1)

Non-Small Cell Lung Cancer (1)

Small Cell Lung Cancer (1)

Urothelial Cancer (1)

Overall Status

Withdrawn (2)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Case Comprehensive Cancer Center (1)

Yale University (1)

Collaborator

Intervention

cdx-1401 (2)

mpdl3280a (1)

pembrolizumab (1)

poly-iclc (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Other (2)

Study Type

Interventional (2)

cdx-1401

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

NSCLC Trial in New Haven (CDX-1401, MPDL3280A)

Withdrawn

Non-Small Cell Lung Cancer

CDX-1401
MPDL3280A

New Haven, Connecticut

Yale University

Jun 21, 2017

Non Small Cell Lung Cancer, Advanced Triple Negative Breast Cancer, Small Cell Lung Cancer Trial (Pembrolizumab, CDX-1401,

Withdrawn

Non Small Cell Lung Cancer
+5 more

Pembrolizumab
+2 more

(no location specified)

Dec 5, 2016